Evidence map›Paper›PMID 35560149›Full record

ArticlePloS one2022

Risk assessment of resistance to diflubenzuron in Musca domestica: Realized heritability and cross-resistance to fourteen insecticides from different classes.

Abdulwahab M Hafez

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Management Practices for the Control ofPathogens (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Abdulwahab M HafezDepartment of Plant Protection, College of Food and Agriculture Sciences, Pesticides and Environmental Toxicology Laboratory, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0003-4290-5548
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Musca domestica L. is a well-known vector for a number of livestock and human diseases. One major challenge for maintaining effective control of this pest is its propensity to develop resistance to insecticides. This study utilized laboratory selection and realized heritability methods to examine the risk of resistance development to diflubenzuron in Musca domestica L. Cross-resistance (CR) to fourteen other insecticides was measured in diflubenzuron-selected (Diflu-SEL) strain which was selected for 20 generations. The resistance ratio (RR) of Diflu-SEL larvae to diflubenzuron increased from 30.33 in generation five (G5) to 182.33 in G24 compared with the susceptible strain, while realized heritability (h2) was 0.08. The number of needed generations (G) for a tenfold increase in the median lethal concentration (LC50) for diflubenzuron ranged from 4 to 45 at h2 values of 0.08, 0.18, and 0.28, at a slope of 1.51. At h2 = 0.08 and slopes of 1.51, 2.51, and 3.51, the number of needed G for a tenfold increase in the LC50 ranged from 9 to 104. The level of CR shown by the Diflu-SEL strain to all other fourteen tested insecticides (insect growth regulators, organophosphates, and pyrethroids) was either absent or very low compared to the field population. The value of h2 and the absent or low CR indicate potential successful management of resistance to diflubenzuron and recommend the use of the tested insecticides in rotation with diflubenzuron to control M. domestica.

Indexed as

DiflubenzuronHousefliesInsecticidesAnimalsHumansInsecticide ResistanceRisk AssessmentDiflubenzuronInsecticides

Identifiers

PMID35560149
PMCPMC9106163
OpenAlexW4280568432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.